MRNS - 3.12 Pre-market now at 4.46/4.47 Marinus Announces Successful Clinical Trial Results and Declares CDKL5 Disorder Its Lead Pediatric Orphan Epilepsy Program for Ganaxolone http://stockcharts.com/c-sc/sc?s=MRNS&p=D&b=5&g=0&i=t99149017026&r=1505135213251 http://stockcharts.com/c-sc/sc?s=MRNS&p=W&b=5&g=0&i=t21697438221&r=1505135194138